Área Sanitaria de Santiago de Compostela e Barbanza
Área sanitaria
Lund University
Lund, SueciaPublicacións en colaboración con investigadores/as de Lund University (130)
2023
-
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry
The European respiratory journal
-
Diminishing benefits of urban living for children and adolescents’ growth and development
Nature, Vol. 615, Núm. 7954, pp. 874-883
-
Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901
2022
-
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
Annals of the rheumatic diseases, Vol. 81, Núm. 7, pp. 970-978
-
Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
Frontiers in Medicine, Vol. 9
-
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries
Arthritis Care and Research, Vol. 74, Núm. 7, pp. 1205-1218
2021
-
Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium
Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 4, pp. 623-642
-
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk
Journal of the National Cancer Institute, Vol. 113, Núm. 3, pp. 329-337
-
Contact dermatitis from glucose sensors in Spain: A multicentric approach
Contact Dermatitis, Vol. 85, Núm. 5, pp. 554-562
-
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score
British Journal of Surgery, Vol. 19, Núm. 4
-
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design: MINOCA-BAT: Rationale and design
American Heart Journal, Vol. 231, pp. 96-104
2020
-
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Nature Communications, Vol. 11, Núm. 1
-
Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” (Pancreatology (2018) 18(8) (847–854), (S1424390318306938), (10.1016/j.pan.2018.09.016))
Pancreatology
-
EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries
Annals of the Rheumatic Diseases, Vol. 79, Núm. 11, pp. 1423-1431
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73
-
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Nature Genetics, Vol. 52, Núm. 6, pp. 572-581
-
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
Scientific reports, Vol. 10, Núm. 1, pp. 9688
-
Repositioning of the global epicentre of non-optimal cholesterol
Nature, Vol. 582, Núm. 7810, pp. 73-77
2019
-
Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations
Pancreatology, Vol. 19, Núm. 4, pp. 488-499
-
Erratum to: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia (Nature Communications, (2018), 9, 1, (1340), 10.1038/s41467-018-03178-z)
Nature Communications